Read more
Informationen zum Autor Kailash Bhatia is a professor of clinical neurology in the Sobell Department of Movement Neuroscience at the Institute of Neurology, UCL, Queen Square, London and an honorary consultant neurologist at the affiliated National Hospital for Neurology, Queen Square. Kailash obtained his basic medical degree and neurology training in Mumbai, India and further training in neurogenetics and movement disorders with the late Professors Anita Harding and David Marsden at the Institute of Neurology, London. In 2007 he was appointed senior lecturer and honorary consultant neurologist, and in 2002 was promoted to professor of clinical neurology. Kailash is a fellow of the Royal College of Physicians and corresponding fellow of the American Academy of Neurology. Professor Bhatia has over 500 publications, including 384 peer-reviewed papers. Kailash has just published “Marsden’s book of Movement disorders?, a comprehensive piece of work which has been highly acclaimed. He is the current Associate Editor of the Movement Disorders Journal. He is a grant reviewer for Telethon, Inserm France, UK PD society and a medical advisor to the UK Dystonia society and on the scientific board of the Bachman Struass trust. He is the current chairman of the Movement Disorders subcommittee of the European Neurological Society (ENS), and serves on various committees of the International Movement Disorders Society. Professor K. Ray Chaudhuri is Professor of Neurology/Movement Disorders at King’s College Hospital and King’s College London and Director of the Parkinson Foundation International Centre of Excellence at King’s College. He is Chairman of the Industry Engagement Committee, and Co Chair Task force of the Parkinson Wellness committee of the Movement Disorders Society (MDS and Ex Chair Membership and Public Relations Committee of the Movement Disorders Society (MDS), was a member of the MDS Congress Scientific Programme Committee (2013-2017) and is Founder and Ex Chairman and current steering group member of the MDS Non-Motor Parkinson’s Disease Study Group and a member of the MDS-ES Education committee and Evidence Based Medicine committee (Nonmotor symptoms). He was the founder -Editor-in-Chief of the njp Parkinson’s Disease (2020 impact factor >8), Guest Editor for special editions of Frontiers in Neurology and Journal of Parkinson’s Disease , reviewer for all mainstream movement disorders journals as well as JAMA , Neurology , Annals of Neurology , BMJ , Brain , Lancet , and Journal of Neurology, Neurosurgery, and Psychiatry . He serves as an advisor (MHRA health technology and scientific advisor) to the UK National Institute for Health and Care Excellence, NHS England, General Medical Council as well as Parkinson’s UK and Parkinson’s Europe. Professor Chaudhuri is the author of over 500 articles, co-editor of 5 books on Parkinson’s disease and restless legs syndrome, and winner of the British Medical Association Book Awards commendation in 2015 and 2017. He is also the recipient of 2018 Jay Van Andel Award Outstanding Achievement in Parkinson’s Disease Research (pioneering holistic assessments and non-motor subtypes), as well as National Institute for Health Research/Royal College of Physicians award for outstanding research leadership in 2017. He was elected honorary member of the Movement Disorders Society in 2021, Honorary Professor Brasov University, Honorary Professor SRM University, India and received the UK NHS Gold merit award in 2021 for excellence in research and clinical service. In 2023 he was featured as “role model? in British Medical Journal. He has been a guest lecturer worldwide, including in Japan, China, Taiwan, Vietnam, Thailand, Singapore, Australia, India, Africa, the US, Russia, and Europe. In 2022/2023 he is ranked fourth in the world for Parkinson’s publications/expertise and expertise since 2...
List of contents
1. Hallmarks of clinical aspects PD throughout centuries 2. The motor syndrome of Parkinson disease 3. The non-motor features of Parkinson's disease 4. The New Diagnostic Criteria for Parkinson's disease 5. Advances in the Clinical Differential diagnosis 6. Clinical assessments in PD : Scales and monitoring 7. Biomarkers of Parkinson's disease: an introduction 8. Genetics of Parkinson's Disease: Genotype-Phenotype Correlations 9. Imaging in pd 10. Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease 11. Hallmarks of treatment aspects - Parkinson's Disease throughout centuries including L-dopa 12. Treatment strategies in early Parkinson's Disease 13. Treatment of non-motor symptoms in Parkinson's disease 14. Treatment of older Parkinson's Disease 15. New symptomatic treatments for the management of motor and non-motor symptoms of Parkinson's disease 16. Device-aided treatment strategies in advanced Parkinson's disease 17. Palliative care for patients and families with Parkinson's disease 18. Multidisciplinary Care in Parkinson's disease
